Φορτώνει......
Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer
IMPORTANCE: The molecular landscape underpinning response to the androgen receptor (AR) antagonist enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) patients is undefined. Consequently, there is an urgent need for practical biomarkers to guide therapy selection and understand r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JAMA Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097690/ https://ncbi.nlm.nih.gov/pubmed/27148695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.0494 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|